Accrued Expenses and Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	December 31,
	2023		2022
Compensation and related benefits	$	3,496	$	3,357
Research and development	4,895		1,800
Accrued severance, bonus, and retention (1)	2,476		—
Accrued offering costs in connection with pre-closing financing	3,334		—
Accrued transaction costs related to reverse merger	2,557		—
Other	737		167
Total accrued expenses and other current liabilities	$	17,495	$	5,324

(1) Includes accrued severance, bonus, and retention payments for current and former Neoleukin employees. Refer to Note 10, Commitments and Contingencies, for further detail.